Cardiol Therapeutics (CRDL) Institutional Ownership $1.10 -0.05 (-4.35%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cardiol Therapeutics (NASDAQ:CRDL)CurrentInstitutional OwnershipPercentage12.49%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$4.09MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.07M Get CRDL Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiol Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRDL Institutional Buying and Selling by Quarter Cardiol Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/18/2025 Lion Street Advisors LLC333,725$318K0.1%+8.5%0.404% 2/21/2025PVG Asset Management Corp487,295$624K3.0%N/A0.590% 2/17/2025Cetera Investment Advisers43,547$56K0.0%N/A0.053% 2/14/2025AdvisorShares Investments LLC882,488$1.13M0.2%-24.6%1.068% 2/13/2025 Envestnet Asset Management Inc.309,684$398K0.0%N/A0.375% 2/11/2025Virtu Financial LLC48,031$61K0.0%N/A0.058% 2/10/2025Tejara Capital Ltd3,115,437$3.99M2.6%+75.9%3.771% 2/6/2025Atria Investments Inc135,891$174K0.0%N/A0.164% 2/6/2025Jones Financial Companies Lllp19,847$25K0.0%N/A0.024% 1/27/2025 Lion Street Advisors LLC307,666$396K0.1%+12.6%0.372% Get the Latest News and Ratings for CRDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Jane Street Group LLC14,759$29K0.0%N/A0.018% 11/13/2024Townsquare Capital LLC13,745$27K0.0%N/A0.017% 10/24/2024 Wealth Enhancement Advisory Services LLC13,700$27K0.0%N/A0.020% 10/21/2024Foundations Investment Advisors LLC161,950$321K0.0%+237.4%0.235% 10/10/2024 Lion Street Advisors LLC273,281$544K0.2%+7.9%0.396% 8/8/2024AdvisorShares Investments LLC1,466,972$2.93M0.5%+12.7%2.126% 8/2/2024Foundations Investment Advisors LLC48,000$97K0.0%N/A0.069% 7/17/2024Baader Bank Aktiengesellschaft29,028$59K0.0%N/A0.042% 7/12/2024 Lion Street Advisors LLC253,281$505K0.2%+31.4%0.367% 5/10/2024MMCAP International Inc. SPC2,566,125$4.65M0.6%-13.1%3.758% 2/14/2024AdvisorShares Investments LLC1,189,978$1M0.2%-1.3%1.821% 2/9/2024AXS Investments LLC697,651$579K0.1%-9.8%1.068% 11/15/2023Tejara Capital Ltd645,457$578K0.3%+29.9%0.996% 11/15/2023Laird Norton Trust Company LLC100,000$90K0.0%+63.1%0.154% 11/13/2023Tejara Capital Ltd645,457$578K0.4%+29.9%0.996% 11/6/2023AdvisorShares Investments LLC1,205,788$1.11M0.3%-1.1%1.861% 10/10/2023 FNY Investment Advisers LLC33,305$30K0.0%N/A0.051% 8/11/2023Tejara Capital Ltd497,061$442K0.2%+12.8%0.775% 8/10/2023AXS Investments LLC1,299,076$1.16M0.3%-24.8%2.026% 8/9/2023AdvisorShares Investments LLC1,219,738$1.09M0.3%+3.4%1.902% 8/2/2023Bank of Montreal Can112,179$110K0.0%N/A0.175% 7/13/2023 Cambridge Investment Research Advisors Inc.76,611$68K0.0%+66.5%0.120% 5/12/2023AXS Investments LLC1,727,827$844K0.3%N/A2.698% 5/11/2023MMCAP International Inc. SPC3,153,400$1.54M0.3%-6.0%4.924% 5/9/2023AdvisorShares Investments LLC1,179,738$575K0.2%+7.2%1.842% 2/9/2023 Mirae Asset Global Investments Co. Ltd.1,094,040$557K0.0%+25.7%1.708% 2/1/2023Bank of Montreal Can90,000$61K0.0%+511.0%0.141% 8/15/2022MMCAP International Inc. SPC3,353,400$4.43M0.4%+3.1%5.414% 8/11/2022Marble Harbor Investment Counsel LLC38,150$50K0.0%+32.0%0.062% 8/2/2022Thompson Davis & CO. Inc.28,400$37K0.0%N/A0.046% The Worst Year in American Financial History? (Ad)Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behind all the chaos you've seen play out in the global economy in 2025. This curse has nothing to do with astrology or anything metaphorical. In fact, it's studied at the highest levels of finance and academia ... and VP Vance even questioned Jerome Powell about it. It's a wild money story you could soon hear everywhere. Only one investigative journalist is telling the story here.Learn the #1 move to protect your wealth now7/26/2022 Mirae Asset Global Investments Co. Ltd.1,356,620$1.78M0.0%-2.3%2.190% 6/2/2022 Mirae Asset Global Investments Co. Ltd.1,388,836$2.15M0.0%+32.9%2.243% 5/11/2022MMCAP International Inc. SPC3,253,400$4.98M0.3%+3.2%7.294% 2/9/2022MMCAP International Inc. SPC3,153,200$5.83M0.4%N/A7.069% 1/25/2022Private Ocean LLC20,651$38K0.0%+275.5%0.046% 1/11/2022 Brookstone Capital Management15,887$27K0.0%N/A0.036% 11/12/2021Renaissance Technologies LLC144,900$598K0.0%N/A0.334% 11/12/2021Vident Investment Advisory LLC50,566$208K0.0%N/A0.117% 11/10/2021Marble Harbor Investment Counsel LLC22,000$91K0.0%N/A0.051% 11/5/2021Advisor Group Holdings Inc.15,800$65K0.0%N/A0.036% (Data available from 1/1/2016 forward) CRDL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRDL shares? During the previous two years, 20 institutional investors and hedge funds held shares of Cardiol Therapeutics. The most heavily invested institutionals were MMCAP International Inc. SPC ($4.65M), Tejara Capital Ltd ($3.99M), AdvisorShares Investments LLC ($1.13M), PVG Asset Management Corp ($624K), AXS Investments LLC ($579K), Envestnet Asset Management Inc. ($398K), and Foundations Investment Advisors LLC ($321K).Learn more on CRDL's institutional investors. What percentage of Cardiol Therapeutics stock is owned by institutional investors? 12.49% of Cardiol Therapeutics stock is owned by institutional investors. Learn more on CRDL's institutional investor holdings. Which institutional investors have been buying Cardiol Therapeutics stock? Of the 19 institutional investors that purchased Cardiol Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AXS Investments LLC ($1.73M), Tejara Capital Ltd ($1.70M), PVG Asset Management Corp ($487.30K), Envestnet Asset Management Inc. ($309.68K), AdvisorShares Investments LLC ($283.94K), Foundations Investment Advisors LLC ($161.95K), and Lion Street Advisors LLC ($141.03K). How much institutional buying is happening at Cardiol Therapeutics? Institutional investors have bought a total of 5,342,422 shares in the last 24 months. This purchase volume represents approximately $5.51M in transactions. Which Cardiol Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cardiol Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($587.18K), AXS Investments LLC ($504.64K), and AdvisorShares Investments LLC ($318.14K). How much institutional selling is happening at Cardiol Therapeutics? Institutional investors have sold a total of 1,409,951 shares in the last 24 months. This volume of shares sold represents approximately $1.64M in transactions. Related Companies CMPS Major Shareholders TKNO Major Shareholders ALLO Major Shareholders TRDA Major Shareholders ARCT Major Shareholders TSHA Major Shareholders HRTX Major Shareholders ATYR Major Shareholders ATAI Major Shareholders PVLA Major Shareholders This page (NASDAQ:CRDL) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.